Biomarin Pharmaceutical (BMRN) Q4 2020 Earnings

5NovConfirmed
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-0.08
1.28
2.65
4.01

Details

Expected EPS
1.87
Actual EPS
4.01
Surprise EPS
2.14
Surprise Percent
+114.44%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 4.01 per share for Q4 2020.

0 Comments

Share your thoughts